Albireo Pharma Incのボラティリティ
Albireo Pharma Incのボラティリティは何ですか。
Albireo Pharma Incのボラティリティは1.53%です。
ボラティリティの定義は何ですか。
ボラティリティまたは平均真の範囲パーセント（ATRP14）は、終値のパーセンテージとして表されるATRです。
Average true range percent (ATRP) measures volatility on a relative level. This is opposed to the ATR, which measures volatility on an absolute level. ATRP allows securities to be compared whereas ATR does not. That means lower-priced stocks won't necessarily have lower ATR values than higher-priced stocks.
The period used in the calculation is 14 days and the normalized indicator oscillates between 0 and 100 percent of recent price variation. Importantly, the indicator doesn't predict the direction of price but it describes the current volatility. The volatility is comparable across all securities and all markets.
Volatility expresses the degree of price movement. The use of ATRP as volatility compared to ATR is preferred in cases when different securities or different time periods are compared. Examples are stock screening, filtering strategies, and studying seasonality and volatility patterns over long periods of time and different markets
NASDAQのセクタHealth Careにおけるボラティリティの企業と比べるAlbireo Pharma Inc
Albireo Pharma Incは何をしますか。
Albireo Pharma is a clinical-stage biopharmaceutical company focused on the development of novel bile acid modulators to treat rare pediatric and adult liver diseases, and other adult liver diseases and disorders. Albireo's lead product candidate, odevixibat, is being developed to treat rare pediatric cholestatic liver diseases with Phase 3 pivotal trials in PFIC, Alagille syndrome and biliary atresia. The Company completed IND-enabling studies for new preclinical candidate A3907 this year and plans to advance development in adult liver disease. Albireo was spun out from AstraZeneca in 2008 and is headquartered in Boston, Massachusetts, with its key operating subsidiary in Gothenburg, Sweden. The Boston Business Journal named Albireo one of the 2020 Best Places to Work in Massachusetts for the second consecutive year.
Albireo Pharma Incと類似のボラティリティ
- 167のボラティリティは1.52%です。
- Csop Asset Management - CSOP Gold Futures Daily (2x) Leveraged Product ETFのボラティリティは1.52%です。
- Sprott Physical Silver Trust Usのボラティリティは1.52%です。
- Cantel Medical Corpのボラティリティは1.52%です。
- GenMark Diagnostics Incのボラティリティは1.52%です。
- iShares Asia Trust - iShares NASDAQ 100 Index ETFのボラティリティは1.52%です。
- Albireo Pharma Incのボラティリティは1.53%です。
- NRJ SAのボラティリティは1.54%です。
- Cap Gemini S.Aのボラティリティは1.54%です。
- Million Starsのボラティリティは1.54%です。
- Rafaella Resourcesのボラティリティは1.54%です。
- Nestlé SAのボラティリティは1.54%です。
- Navy Resourcesのボラティリティは1.54%です。